Barclays’s Kindred Healthcare KND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-14,900
| Closed | -$134K | – | 7681 |
|
|
2018
Q2 | $134K | Buy |
14,900
+12,700
| +577% | +$114K | ﹤0.01% | 5055 |
|
|
2018
Q1 | $20K | Sell |
2,200
-23,800
| -92% | -$220K | ﹤0.01% | 6444 |
|
|
2017
Q4 | $252K | Buy |
26,000
+22,600
| +665% | +$168K | ﹤0.01% | 4489 |
|
|
2017
Q3 | $23K | Buy |
3,400
+2,400
| +240% | +$20.4K | ﹤0.01% | 5747 |
|
|
2017
Q2 | $12K | Buy |
1,000
+500
| +100% | +$4.93K | ﹤0.01% | 6006 |
|
|
2017
Q1 | $4K | Sell |
500
-10,800
| -96% | -$84.5K | ﹤0.01% | 6365 |
|
|
2016
Q4 | $89K | Sell |
11,300
-8,100
| -42% | -$66.5K | ﹤0.01% | 4832 |
|
|
2016
Q3 | $198K | Buy |
19,400
+10,000
| +106% | +$111K | ﹤0.01% | 3980 |
|
|
2016
Q2 | $106K | Buy |
9,400
+8,000
| +571% | +$100K | ﹤0.01% | 4362 |
|
|
2016
Q1 | $17K | Buy |
+1,400
| New | +$14.5K | ﹤0.01% | 5291 |
|
|
2015
Q4 | – | Sell |
-200
| Closed | -$3K | – | 6960 |
|
|
2015
Q3 | $3K | Sell |
200
-1,700
| -89% | -$34.4K | ﹤0.01% | 6270 |
|
|
2015
Q2 | $38K | Buy |
1,900
+1,700
| +850% | +$38.9K | ﹤0.01% | 5324 |
|
|
2015
Q1 | $5K | Buy |
+200
| New | +$4.06K | ﹤0.01% | 6634 |
|
|
2014
Q4 | – | Sell |
-1,100
| Closed | -$21K | – | 7787 |
|
|
2014
Q3 | $21K | Sell |
1,100
-1,000
| -48% | -$21.8K | ﹤0.01% | 6467 |
|
|
2014
Q2 | $48K | Buy |
2,100
+1,400
| +200% | +$34.2K | ﹤0.01% | 5978 |
|
|
2014
Q1 | $16K | Hold |
700
| – | – | ﹤0.01% | 6721 |
|
|
2013
Q4 | $13K | Sell |
700
-1,200
| -63% | -$19.3K | ﹤0.01% | 6910 |
|
|
2013
Q3 | $25K | Sell |
1,900
-13,900
| -88% | -$200K | ﹤0.01% | 6436 |
|
|
2013
Q2 | $207K | Buy |
+15,800
| New | +$189K | ﹤0.01% | 5143 |
|
Barclays's KND Position: Q3 2018 in Review
Barclays sold out of Kindred Healthcare (KND) in Q3 2018, closing a stake of 325,463 shares — an estimated $2.93M sold.
Barclays first reported a position in KND in Q2 2013 and held it in 21 quarters. The position peaked at $5.47M in Q3 2014. 0 funds tracked by Wall St. Rank hold KND as of Q3 2018.
- Barclays reported no remaining Kindred Healthcare position as of Q3 2018 after selling out during the quarter.
- Barclays sold 325,463 Kindred Healthcare shares in Q3 2018, an estimated $2.93M.
- Barclays first reported a position in Kindred Healthcare in Q2 2013 and held it in 21 quarters.
- Barclays's Kindred Healthcare position peaked at $5.47M in Q3 2014.
- 0 funds tracked by Wall St. Rank held Kindred Healthcare as of Q3 2018.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.